Westfield Capital Management Co. LP Acquires 599,589 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Westfield Capital Management Co. LP boosted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 10.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,492,152 shares of the company's stock after purchasing an additional 599,589 shares during the quarter. Option Care Health comprises approximately 0.9% of Westfield Capital Management Co. LP's investment portfolio, making the stock its 18th biggest position. Westfield Capital Management Co. LP owned about 3.81% of Option Care Health worth $203,204,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of OPCH. Massachusetts Financial Services Co. MA bought a new position in Option Care Health during the second quarter worth about $68,003,000. Victory Capital Management Inc. increased its holdings in shares of Option Care Health by 4,432.8% during the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company's stock worth $50,756,000 after purchasing an additional 1,585,818 shares during the period. Magnetar Financial LLC raised its position in shares of Option Care Health by 124.8% in the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company's stock valued at $68,750,000 after buying an additional 1,377,929 shares in the last quarter. Duquesne Family Office LLC boosted its stake in shares of Option Care Health by 172.8% in the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company's stock valued at $51,849,000 after buying an additional 1,185,613 shares during the period. Finally, Geneva Capital Management LLC acquired a new stake in Option Care Health during the third quarter worth approximately $24,679,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Trading Up 2.8 %

OPCH traded up $0.64 during trading on Friday, reaching $23.13. 1,638,831 shares of the company's stock were exchanged, compared to its average volume of 3,016,309. The firm has a fifty day moving average price of $27.62 and a two-hundred day moving average price of $29.09. The stock has a market capitalization of $3.94 billion, a PE ratio of 19.44, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm's stock in a transaction on Friday, November 8th. The stock was acquired at an average price of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares of the company's stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several analyst reports. The Goldman Sachs Group cut Option Care Health from a "buy" rating to a "neutral" rating and dropped their price objective for the company from $38.00 to $27.00 in a report on Monday, November 4th. Barrington Research reduced their price objective on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a research note on Thursday, October 31st. Truist Financial decreased their target price on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a report on Friday, November 1st. Jefferies Financial Group lowered shares of Option Care Health from a "buy" rating to a "hold" rating and reduced their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Finally, JMP Securities boosted their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a research report on Monday, September 30th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $30.83.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.